These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14452116)

  • 21. [Salicylamide and salicylic acid poisoning in the cat in comparison with other animals. 3].
    BEKEMEIER H; HASCHEN RJ; SEIPELT H
    Arzneimittelforschung; 1962 Jul; 12():707-9. PubMed ID: 13866648
    [No Abstract]   [Full Text] [Related]  

  • 22. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
    Peretti E; Karlaganis G; Lauterburg BH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the metabolism of salicylamide-[14C]].
    WEYGAND F; BECHER A; FELDMANN D; GROSSKINSKY OA
    Hoppe Seylers Z Physiol Chem; 1953 Jun; 292(3-5):138-49. PubMed ID: 13095954
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
    Nair CR; Gupta RC; Varshneya AK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of the metabolism of C14 salicylamide in the human.
    MANDEL HG; RODWELL VW; SMITH PK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):433-9. PubMed ID: 13023553
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetylation of procainamide and isoniazid by a rat liver-N-acetyl-transferase.
    Kattner E; Dubbels R; Schloot W
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):81-4. PubMed ID: 6974093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salicylamide I. Absorption, excretion, and blood levels.
    CRAMPTON JM; VOSS E
    J Am Pharm Assoc Am Pharm Assoc; 1954 Aug; 43(8):470-3. PubMed ID: 13191992
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of an MAO inhibitor, phenelzine, on acetylation of isoniazid by isolated perfused rat liver].
    Notter D; Catau G; Besson S
    C R Seances Soc Biol Fil; 1978; 172(3):529-30. PubMed ID: 153184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolism of salicylamide in man].
    BECHER A; MIKSCH J; RAMBACHER P; SCHAFER A
    Klin Wochenschr; 1952 Oct; 30(39-40):913-8. PubMed ID: 13001153
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isoniazid acetylation in Gilbert's syndrome].
    Pereira-Filho RA; Sevá-Pereira A; de Magalhães AF
    Arq Gastroenterol; 1985; 22(4):172-5. PubMed ID: 3837656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of salicylamide; effect of combining salicylamide with sodium salicylate and acetyl-salicylic acid on the lethality of these substances for white mouse.
    PAASONEN M; PELTONEN T
    Ann Med Exp Biol Fenn; 1952; 30(2):172-9. PubMed ID: 13040872
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylation of isoniazid.
    Eidus L; Hodgkin MM
    J Antimicrob Chemother; 1977 Nov; 3(6):626-7. PubMed ID: 599127
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intravenous salicylamide therapy in rheumatic diseases].
    FRANKL R
    Munch Med Wochenschr; 1953 Apr; 95(17):512-3. PubMed ID: 13072425
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of isoniazid metabolism in man.
    Ellard GA; Gammon PT
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):83-113. PubMed ID: 950592
    [No Abstract]   [Full Text] [Related]  

  • 36. A note on serum levels and excretion of salicylamide in man.
    HIDALGO J; SEEBERG VP
    J Am Pharm Assoc Am Pharm Assoc; 1955 Jun; 44(6):384. PubMed ID: 14381318
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolism of isoniazid and para-amino salicylic acid (PAS) in the organism and its therapeutic significance.
    BANG HO; JACOBSEN LK; STRANDGAARD E; YDE H
    Acta Tuberc Pneumol Scand; 1962; 41():237-51. PubMed ID: 13864641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting the metabolism of [14C]acetylhydrazine in rats.
    Wright JM; Timbrell JA
    Drug Metab Dispos; 1978; 6(5):561-6. PubMed ID: 30606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.